Arzneimittelwerk Warngau

company

About

Arzneimittelwerk Warngau develops and markets drug delivery systems.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€25M
Industries
Emergency Medicine,Health Care,Health Diagnostics,Medical,Medical Device,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants.

Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€38M
Arzneimittelwerk Warngau has raised a total of €38M in funding over 2 rounds. Their latest funding was raised on Jan 4, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 4, 2018 Series Unknown €25M 1 European Investment Bank Detail
Jul 21, 2016 Series C €6M 1 Bayern Kapital Detail
Jun 3, 2015 Series B €7M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Arzneimittelwerk Warngau is funded by 2 investors. European Investment Bank and Bayern Kapital are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Series Unknown
Bayern Kapital Yes Series C